Even as researchers seek for biomarkers to forecast ketamine response, clinicians discover themselves with a conundrum: Which patients must start with IV ketamine, and which with Spravato? And exactly how do the two compare head to head in true response to treatment?The mechanism by which opioids produce hyperalgesia is paradoxical also, in that hy